Schroder Capital Global Innovation Trust (formerly Schroder UK Public Private Trust : SUPP, and before that Woodford Patient Capital Trust : WPCT) aims to achieve long-term capital growth by investing in a diversified portfolio of 30-40 highly innovative companies on an upward trajectory, wherever they may be in the world.
Initially, the fund was distinguished by being the largest new issue of an investment trust at the time of launch and by having an unusual fee structure whereby the manager would only receive performance fees and no basic management fee. Later, the trust became embroiled in the collapse of Woodford Investment Management. Schroders were appointed managers on 13 December 2019. Under Schroders, the management fee is 1.0% a year on market capitalisation up to £600m and 0.8% above that. There is a performance fee too but this doesn’t kick in until the end of 2022.
You can access the fund’s website here.
You can view our interviews with the company’s Fund Managers below:
1st October 2021: Tim Creed – Weekly Show